Non-equilibrium snapshots of ligand efficacy at the μ-opioid receptor.

Summary

Using time-resolved cryo-EM, the authors captured non-equilibrium intermediate states of MOR-Gi signaling when MOR was bound to ligands of differing efficacy (partial, full, super-agonists). Structural features observed under GTP-driven activation provide a mechanistic basis for efficacy differences, advancing structure–efficacy relationships for opioid pharmacology.

Key Findings

• Time-resolved cryo-EM captured non-equilibrium intermediate states of MOR-Gαiβγ activation.
• MOR bound to partial, full, and super-agonists displayed structurally distinct activation trajectories under GTP.
• Structural snapshots provide a mechanistic basis for ligand efficacy differences at MOR.

Clinical Implications

While preclinical, these insights can guide development of opioid ligands biased toward desired signaling and efficacy, potentially improving analgesia while minimizing respiratory depression and dependence.

Limitations

• In vitro structural study without direct in vivo validation
• Non-equilibrium preparation may not capture all physiological conformational states

Future Directions

Integrate TR cryo-EM with functional assays to link structural intermediates to signaling outcomes and test structure-guided ligand design for biased opioid pharmacology.